Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23,633 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Autologous hematopoietic stem cell transplantation activity for lymphoma and multiple myeloma in China.
Liu W, Ji J, Zou D, Cao Y, Xu Y, Zhou J, Gao S, Wang F, Chen W, Du J, Zhou H, Zhou F, Shi J, Zhang X, Yang J, Jing H, Jiang Z, Liu H, Li C, Peng H, Jiang S, Wei X, He P, Liu Y, Yang H, Li Z, Huang X, Liu L, Shen L, Liu C, Song Y, Qiu L, Wang X, Ma J, Zhu J. Liu W, et al. Among authors: shi j. Bone Marrow Transplant. 2023 Mar;58(3):349-352. doi: 10.1038/s41409-022-01899-w. Epub 2022 Dec 17. Bone Marrow Transplant. 2023. PMID: 36528754 No abstract available.
Allogeneic hematopoietic stem cell transplantation should be in preference to conventional chemotherapy as post-remission treatment for adults with lymphoblastic lymphoma.
Yang L, Tan Y, Shi J, Zhao Y, Zhu Y, Hu Y, Pan W, Ye Y, He J, Zheng W, Sun J, Cai Z, Huang H, Luo Y. Yang L, et al. Among authors: shi j. Bone Marrow Transplant. 2018 Oct;53(10):1340-1344. doi: 10.1038/s41409-018-0184-7. Epub 2018 Apr 30. Bone Marrow Transplant. 2018. PMID: 29712994 Free PMC article. No abstract available.
A retrospective comparison of allogenic and autologous chimeric antigen receptor T cell therapy targeting CD19 in patients with relapsed/refractory acute lymphoblastic leukemia.
Hu Y, Wang J, Wei G, Yu J, Luo Y, Shi J, Wu W, Zhao K, Xiao L, Zhang Y, Wu Z, Xu H, Chang AH, Huang H. Hu Y, et al. Among authors: shi j. Bone Marrow Transplant. 2019 Aug;54(8):1208-1217. doi: 10.1038/s41409-018-0403-2. Epub 2018 Dec 5. Bone Marrow Transplant. 2019. PMID: 30518980
Pre-transplant MRD negativity predicts favorable outcomes of CAR-T therapy followed by haploidentical HSCT for relapsed/refractory acute lymphoblastic leukemia: a multi-center retrospective study.
Zhao H, Wei J, Wei G, Luo Y, Shi J, Cui Q, Zhao M, Liang A, Zhang Q, Yang J, Li X, Chen J, Song X, Jing H, Li Y, Hao S, Wu W, Tan Y, Yu J, Zhao Y, Lai X, Yin ETS, Wei Y, Li P, Huang J, Wang T, Blaise D, Xiao L, Chang AH, Nagler A, Mohty M, Huang H, Hu Y. Zhao H, et al. Among authors: shi j. J Hematol Oncol. 2020 May 4;13(1):42. doi: 10.1186/s13045-020-00873-7. J Hematol Oncol. 2020. PMID: 32366260 Free PMC article. Clinical Trial.
Correction: Allogeneic hematopoietic stem cell transplantation should be in preference to conventional chemotherapy as post-remission treatment for adults with lymphoblastic lymphoma.
Yang L, Tan Y, Shi J, Zhao Y, Zhu Y, Hu Y, Pan W, Ye Y, He J, Zheng W, Sun J, Cai Z, Huang H, Luo Y. Yang L, et al. Among authors: shi j. Bone Marrow Transplant. 2020 Oct;55(10):2056. doi: 10.1038/s41409-020-0962-x. Bone Marrow Transplant. 2020. PMID: 32541688 Free PMC article.
Maintenance sorafenib is superior to prophylactic donor lymphocyte infusion at improving the prognosis of acute myeloid leukemia with FMS-like tyrosine kinase 3 internal tandem duplication after allogeneic hematopoietic stem cell transplantation.
Shi J, Cao L, Luo Y, Zhao Y, Tan Y, Yu J, Lai X, Zhu Y, Hu Y, He J, Sun J, Zheng W, Wei G, Huang H. Shi J, et al. Bone Marrow Transplant. 2021 Jan;56(1):293-296. doi: 10.1038/s41409-020-01015-w. Epub 2020 Aug 4. Bone Marrow Transplant. 2021. PMID: 32753705 No abstract available.
23,633 results
You have reached the last available page of results. Please see the User Guide for more information.